DK0968222T3 - Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents

Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Info

Publication number
DK0968222T3
DK0968222T3 DK98912554T DK98912554T DK0968222T3 DK 0968222 T3 DK0968222 T3 DK 0968222T3 DK 98912554 T DK98912554 T DK 98912554T DK 98912554 T DK98912554 T DK 98912554T DK 0968222 T3 DK0968222 T3 DK 0968222T3
Authority
DK
Denmark
Prior art keywords
drugs
processes
preparation
nar
formula
Prior art date
Application number
DK98912554T
Other languages
Danish (da)
English (en)
Inventor
Constantin Agouridas
Jean-Francois Chantot
Alexis Denis
Claude Fromentin
Jean-Marie Pejac
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0968222T3 publication Critical patent/DK0968222T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK98912554T 1997-02-27 1998-02-26 Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler DK0968222T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702352A FR2760017B1 (fr) 1997-02-27 1997-02-27 Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1998/000378 WO1998038199A1 (fr) 1997-02-27 1998-02-26 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
DK0968222T3 true DK0968222T3 (da) 2002-10-07

Family

ID=9504247

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912554T DK0968222T3 (da) 1997-02-27 1998-02-26 Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Country Status (21)

Country Link
EP (1) EP0968222B1 (ko)
JP (1) JP4531136B2 (ko)
KR (1) KR100529980B1 (ko)
CN (1) CN1162442C (ko)
AT (1) ATE219097T1 (ko)
AU (1) AU728182B2 (ko)
BR (1) BR9807795A (ko)
CA (1) CA2282666C (ko)
DE (1) DE69805981T2 (ko)
DK (1) DK0968222T3 (ko)
EA (1) EA002359B1 (ko)
ES (1) ES2179475T3 (ko)
FR (1) FR2760017B1 (ko)
HU (1) HUP0001245A3 (ko)
IL (1) IL131340A0 (ko)
NO (1) NO315653B1 (ko)
PL (1) PL187947B1 (ko)
PT (1) PT968222E (ko)
TR (1) TR199902092T2 (ko)
WO (1) WO1998038199A1 (ko)
ZA (1) ZA981482B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782239A1 (fr) 1998-08-13 2000-02-18 Euromark Benne a racleur integre pour la distribution de produits destines a l'elevage
ES2243066T3 (es) 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
BR9916969A (pt) 1999-01-27 2001-11-06 Pfizer Prod Inc Antibióticos cetólidos
ES2272273T3 (es) * 1999-04-16 2007-05-01 Kosan Biosciences, Inc. Agentes antiinfecciosos macrolidos.
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
US6673774B2 (en) 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
US6670331B2 (en) 2001-12-04 2003-12-30 Enanta Pharmaceuticals, Inc. 11-O-substituted ketolide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
EP0968222A1 (fr) 2000-01-05
ES2179475T3 (es) 2003-01-16
BR9807795A (pt) 2000-02-15
EA002359B1 (ru) 2002-04-25
DE69805981D1 (de) 2002-07-18
PL187947B1 (pl) 2004-11-30
KR20000075722A (ko) 2000-12-26
IL131340A0 (en) 2001-01-28
CA2282666A1 (fr) 1998-09-03
EA199900765A1 (ru) 2000-04-24
AU6734798A (en) 1998-09-18
JP2001513101A (ja) 2001-08-28
CA2282666C (fr) 2008-09-02
ATE219097T1 (de) 2002-06-15
EP0968222B1 (fr) 2002-06-12
NO994150D0 (no) 1999-08-27
WO1998038199A1 (fr) 1998-09-03
PT968222E (pt) 2002-10-31
CN1162442C (zh) 2004-08-18
JP4531136B2 (ja) 2010-08-25
PL335375A1 (en) 2000-04-25
CN1248261A (zh) 2000-03-22
KR100529980B1 (ko) 2005-11-22
FR2760017A1 (fr) 1998-08-28
TR199902092T2 (xx) 2000-05-22
HUP0001245A1 (hu) 2000-09-28
HUP0001245A3 (en) 2003-05-28
FR2760017B1 (fr) 1999-04-30
DE69805981T2 (de) 2003-01-16
NO994150L (no) 1999-08-27
ZA981482B (en) 1999-02-23
NO315653B1 (no) 2003-10-06
AU728182B2 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
EA200970171A1 (ru) Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
EA199901016A1 (ru) 9-оксим-производные эритромицина
WO2007048065A3 (en) Pyrimidinones as casein kinase ii (ck2) modulators
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BRPI0413151A (pt) derivados de amino propanol
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
NO20062202L (no) Amidometylsubstituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater, fremgangsmate og mellomprodukter for deres fremstilling, og legemidler som inneholder disse forbindelsene
DK0968222T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DE69920362D1 (de) Neue Makrolidderivate
CA2302943A1 (en) Phthalazine compounds and therapeutic agents for erectile dysfunction
AP9801377A0 (en) Tricyclic erythromycin derivatives.
BRPI0407386A (pt) Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους
BRPI0207102A8 (pt) forma cristalina, composição farmacêutica, e, uso de uma forma cristalina.
DK1532098T3 (da) Fremgangsmåde til fremstilling af nitrooxyderivater af naproxen
DK1325923T3 (da) Cephem-forbindelser og ESBL-detekterende reagenser indeholdende disse
NO20025209D0 (no) Cyklipostiner, deres fremstilling og anvendelse
NO20002321L (no) Bifenylderivater som farmasøytiske midler
DK1000952T3 (da) Nye 2-halogen-derivater af 5-O-deosaminylerythronolid A, fremgangsmåde til fremstilling deraf samt anvendelse deraf som lægemidler
NO993124L (no) Nye erytromycinderivater, fremgangsmåte for fremstilling av disse samt deres anvendelse som medisiner
IT1213440B (it) 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono.
TH60262A (th) อนุพันธ์ 1,4-ไดอะซาไบไซโคล[3.2.2]โนเนนเบนซอกซาโซล, -เบนโซไทอะโซล และ-เบนซิมิดาโซล, การเตรียมสารดังกล่าวและการใช้ในการบำบัด